Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Jeffrey B, Washam"'
Autor:
Jennifer A. Rymer, Deepak L. Bhatt, Dominick J. Angiolillo, Miguel Diaz, Kirk N. Garratt, Ron Waksman, Laura Edwards, Gudaye Tasissa, Khalid Salahuddin, Hijrah El‐Sabae, Carmen Dell’Anna, Linda Davidson‐Ray, Jeffrey B. Washam, E. Magnus Ohman, Tracy Y. Wang
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 11 (2022)
Background In clinical trials, cangrelor has been shown to reduce percutaneous coronary intervention–related ischemic complications without increasing major bleeding. This study was performed to examine cangrelor use and transition to oral P2Y12 in
Externí odkaz:
https://doaj.org/article/dd326c0c0df844739daea9df80309174
Autor:
Sean D, Pokorney, Glenn M, Chertow, Hussein R, Al-Khalidi, Dianne, Gallup, Pat, Dignacco, Kurt, Mussina, Nisha, Bansal, Crystal A, Gadegbeku, David A, Garcia, Samira, Garonzik, Renato D, Lopes, Kenneth W, Mahaffey, Kelly, Matsuda, John P, Middleton, Jennifer A, Rymer, George H, Sands, Ravi, Thadhani, Kevin L, Thomas, Jeffrey B, Washam, Wolfgang C, Winkelmayer, Christopher B, Granger
Publikováno v:
Circulation. 146:1735-1745
Background: There are no randomized data evaluating the safety or efficacy of apixaban for stroke prevention in patients with end-stage kidney disease on hemodialysis and with atrial fibrillation (AF). Methods: The RENAL-AF trial (Renal Hemodialysis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9c0b7759c9aa8239926cc0bf362ad92
https://doi.org/10.1161/circulationaha.121.054990
https://doi.org/10.1161/circulationaha.121.054990
Autor:
Jeffrey B. Washam, DaJuanicia N. Holmes, Laine E. Thomas, Sean D. Pokorney, Elaine M. Hylek, Gregg C. Fonarow, Kenneth W. Mahaffey, Bernard J. Gersh, Peter R. Kowey, Jack E. Ansell, Alan S. Go, James A. Reiffel, James V. Freeman, Daniel E. Singer, Gerald Naccarelli, Rosalia Blanco, Eric D. Peterson, Jonathan P. Piccini
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 18 (2018)
Background Chronic kidney disease (CKD) is a common comorbidity in patients with atrial fibrillation. The presence of CKD complicates drug selection for stroke prevention and rhythm control. Methods and Results Patients enrolled in ORBIT AF (Outcomes
Externí odkaz:
https://doaj.org/article/0ef1abfb713f46d0b6b200b18ab7877d
Autor:
Subhash Banerjee, E. Magnus Ohman, Sunil V. Rao, Alexander E. Sullivan, Michael G. Nanna, W. Schuyler Jones, Dominick J. Angiolillo, Jeffrey B. Washam, Deepak L. Bhatt, Jennifer A. Rymer, Sarah Cantrell, Roxana Mehran, Tracy Y. Wang
Publikováno v:
Journal of the American College of Cardiology. 78:1550-1563
Patients undergoing early surgery after coronary stent implantation are at increased risk for mortality from ischemic and hemorrhagic complications. The optimal antiplatelet strategy in patients who cannot discontinue dual antiplatelet therapy (DAPT)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a078df68127c7679c436cb834e84afd2
https://doi.org/10.1016/j.jacc.2021.08.013
https://doi.org/10.1016/j.jacc.2021.08.013
Autor:
Da Juanicia N. Holmes, Laine Thomas, James A. Reiffel, Bernard J. Gersh, Daniel E. Singer, Gregg C. Fonarow, Eric D. Peterson, Peter Shrader, James V. Freeman, Gerald V. Naccarelli, Jonathan P. Piccini, Peter R. Kowey, Jeffrey B. Washam, Sean D. Pokorney, Kenneth W. Mahaffey
Publikováno v:
American Heart Journal. 220:145-154
Amiodarone is the most effective antiarrhythmic drug (AAD) for atrial fibrillation (AF), but it has a high incidence of adverse effects.Using the ORBIT AF registry, patients with AF on amiodarone at enrollment, prescribed amiodarone during follow-up,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b947ef034ff01dfb3d52493d996b1d08
https://doi.org/10.1016/j.ahj.2019.09.017
https://doi.org/10.1016/j.ahj.2019.09.017
Autor:
David A. Garcia, Lars Wallentin, Hillary Mulder, Sana M. Al-Khatib, Bernard J. Gersh, Renato D. Lopes, Daniel Wojdyla, Elaine M. Hylek, Claes Held, Jeffrey B. Washam, Raffaele De Caterina, John H. Alexander, Frederik Dalgaard, Christopher B. Granger
Publikováno v:
Circulation. 141:10-20
Background: The use of nonsteroidal anti-inflammatory drugs (NSAIDs) with oral anticoagulants has been associated with an increased risk of bleeding. We investigated the risk of bleeding and major cardiovascular outcomes in patients with atrial fibri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5185c3e3a4e7fe44757704ad4547573d
https://doi.org/10.1161/circulationaha.119.041296
https://doi.org/10.1161/circulationaha.119.041296
Autor:
Alexander E, Sullivan, Michael G, Nanna, Tracy Y, Wang, Deepak L, Bhatt, Dominick J, Angiolillo, Roxana, Mehran, Subhash, Banerjee, Sarah, Cantrell, W Schuyler, Jones, Jennifer A, Rymer, Jeffrey B, Washam, Sunil V, Rao, E Magnus, Ohman
Publikováno v:
Journal of the American College of Cardiology. 78(15)
Patients undergoing early surgery after coronary stent implantation are at increased risk for mortality from ischemic and hemorrhagic complications. The optimal antiplatelet strategy in patients who cannot discontinue dual antiplatelet therapy (DAPT)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::22141e53405df151a7362eacf8c9ce94
https://pubmed.ncbi.nlm.nih.gov/34620413
https://pubmed.ncbi.nlm.nih.gov/34620413
Autor:
Jeffrey B. Washam, Jonathan P. Piccini
Publikováno v:
JACC: Clinical Electrophysiology. 6:491-493
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e840c3b142573fb4637cc74e6462c5c3
https://doi.org/10.1016/j.jacep.2020.02.011
https://doi.org/10.1016/j.jacep.2020.02.011
Autor:
Daniel Wojdyla, Stefan H. Hohnloser, Bernard J. Gersh, Renato D. Lopes, Elaine M. Hylek, Michael G. Hanna, Lars Wallentin, Denis Xavier, John D. Horowitz, Christopher B. Granger, Jeffrey B. Washam, Freek W.A. Verheugt, John H. Alexander, Dragos Vinereanu
Publikováno v:
Journal of Thrombosis and Thrombolysis, 47, 3, pp. 345-352
Journal of Thrombosis and Thrombolysis, 47, 345-352
Journal of Thrombosis and Thrombolysis, 47, 345-352
Contains fulltext : 202664.pdf (Publisher’s version ) (Closed access) Warfarin is dependent on multiple hepatic enzymes for metabolism while apixaban is a substrate for P-glycoprotein (P-gp) transport and hepatic CYP3A4 metabolism. The aim of this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::863e9ac3456285d27752fb9fe9cdc730
https://hdl.handle.net/2066/202664
https://hdl.handle.net/2066/202664
Autor:
Sean van Diepen, Steven M. Hollenberg, Christopher B. Fordyce, Jason N. Katz, Bram J. Geller, Jeffrey B. Washam, Vascular Biology, Erin A. Bohula, Daniel B. Sims, Cynthia Arslanian-Engoren, Carlos L. Alviar, Jacob C. Jentzer
Publikováno v:
Circulation. 142
Contemporary cardiac intensive care units (CICUs) have an increasing prevalence of noncardiovascular comorbidities and multisystem organ dysfunction. However, little guidance exists to support the development of best-practice principles specific to t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::decb8c863acad6934cc7ae2dd2364524
https://doi.org/10.1161/cir.0000000000000909
https://doi.org/10.1161/cir.0000000000000909